GSTP1 and COVID-19: In line with our previous findings on smaller cohort, carriers of GSTP1*IleVal + ValVal and GSTP1*AlaVal + ValVal genotype exhibited significantly lower risk of COVID-19 development (crude OR = 0.61, 95%CI: 0.41–0.88, p = 0.009 and crude OR = 0.56, 95% CI: 0.37–0.84, p = 0.005, respectively) compared to wild-type genotypes, which was even more pronounced in the adjusted analysis (OR = 0.38, 95%CI: 0.22–0.65, p ˂ 0.001 and OR = 0.42, 95%CI: 0.24–0.73, p = 0.002, respectively).